Propionat 100

Propionat 100 Dragon Pharma — Overview

Propionat 100 Dragon Pharma is testosterone propionate at 100 mg/ml — the short-ester form of testosterone with a half-life of approximately 2–3 days. The propionate ester is the fastest-clearing of the three primary injectable testosterone formats; blood levels build within the first week and return to baseline within 5–7 days of the last injection, enabling PCT to begin 3–5 days post-cycle — faster than any other testosterone ester. This combination of fast onset, stable EOD (every other day) blood levels, and rapid clearance makes Propionat 100 the preferred testosterone base in pre-contest protocols and in cycles where minimum post-cycle wait time matters.

The active compound is testosterone — the same hormone produced endogenously, functioning as the reference standard against which all other AAS anabolic and androgenic ratings are measured (100/100). Testosterone propionate aromatizes to estradiol, suppresses the HPG axis completely during the cycle, and produces the full spectrum of testosterone's anabolic effects: lean mass accumulation, strength increase, erythropoiesis, nitrogen retention, and androgenic environment maintenance. Available at Steroid Warehouse at 100 mg/ml, Propionat 100 Dragon Pharma is the standard short-ester testosterone for athletes who need testosterone's full pharmacological profile with the speed and flexibility of the propionate ester.

About the Compound: Testosterone Propionate

Testosterone propionate is testosterone attached to the propionate ester — a short, 3-carbon chain that slows the release of testosterone from the injection site relative to unmodified testosterone but produces much faster clearance than medium- or long-chain esters such as enanthate (7-carbon) or cypionate (8-carbon). After intramuscular injection, the ester undergoes enzymatic hydrolysis, releasing free testosterone into circulation. The rate of release is governed entirely by the ester chain length: the propionate ester's short chain produces a half-life of approximately 2–3 days, requiring injection every other day or every third day to maintain stable blood levels.

Free testosterone is biologically identical regardless of which ester delivers it; pharmacological effects, aromatization rate, androgenicity, and anabolism are the same as with enanthate or cypionate at equivalent steady-state concentrations. What the ester changes exclusively is the pharmacokinetic profile — how fast levels build, how stable they remain between injections, and how quickly they return to baseline after the last dose. Propionate's 2–3 day half-life means that steady-state blood levels are reached in approximately 7–10 days (compared to 3–4 weeks for enanthate); it also means that levels fall to near-baseline within 5–7 days of the last injection, enabling PCT to start 3–5 days post-cycle rather than the 2-week wait required for long esters.

Testosterone aromatizes to estradiol (E2) via the aromatase enzyme; estrogen management is required on any testosterone cycle. Testosterone is not 17α-alkylated and produces no hepatotoxicity. It suppresses endogenous LH and FSH completely through HPG axis negative feedback, requiring post-cycle therapy for HPTA recovery. At 100 mg/ml, each 1 ml injection of Propionat 100 delivers 100 mg of propionate-esterified testosterone, yielding approximately 83 mg of free testosterone after ester hydrolysis (propionate ester molecular weight reduction factor).

What Propionat 100 Does

• Full testosterone anabolic and androgenic activity — testosterone propionate delivers the complete pharmacological profile of testosterone: androgen receptor activation driving nitrogen retention and protein synthesis, anabolic signaling for lean mass accrual, erythropoiesis stimulation increasing red blood cell mass and oxygen delivery, and the androgenic tissue effects (libido, mood, energy, bone density maintenance) that make testosterone the mandatory base for all AAS cycles; the propionate ester does not alter this profile — it only determines the kinetic delivery curve
• Fast blood level build-up and stable EOD kinetics — the 2–3 day half-life means blood levels reach steady state within 7–10 days of starting injections; users typically notice androgenic effects and changes in training output within the first 1–2 weeks, significantly earlier than the 3–4 week onset of enanthate or cypionate; the EOD injection schedule maintains stable peaks and troughs without the fluctuations that occur with less frequent long-ester dosing
• Rapid clearance enabling fast PCT and short cycles — the propionate ester's short chain clears to baseline within 5–7 days of the last injection; PCT begins 3–5 days post-last-dose; this makes 8-week cycles practical in a way that is not possible with long esters (which require a 2-week post-cycle wait before PCT even begins, extending the total recovery timeline); for athletes managing time between cycles, propionate's fast clearance compresses the recovery window significantly
• Estrogen-supported anabolic environment — testosterone's aromatization to estradiol is a feature, not only a liability; estrogen supports IGF-1 production, joint lubrication, mood stability, libido, and bone mineralization; the goal is not to eliminate E2 but to manage it within an optimal range (20–40 pg/mL); properly managed estrogen on a testosterone cycle contributes to both anabolic output and wellbeing; over-suppression of E2 with aggressive AI use negates these benefits
• Versatile base for any cycle goal — testosterone propionate is used as the base in bulking, cutting, and competition-prep protocols; the dosing range adjusts the goal: at 300–350 mg/week it functions as a TRT-level base for dry stack cycles (with Primobolan, Masteron, or Trenbolone driving the anabolic work); at 400–500 mg/week it contributes meaningfully to mass and strength; its primary use-case advantage over long esters is timing — when cycle duration, clearance speed, or injection frequency control matter

Who It's For

• Athletes using propionate as a pre-contest or dry-stack testosterone base — the most common specific use case for propionate over enanthate or cypionate is pre-contest: keeping testosterone base low (200–300 mg/week) to maintain androgenic function and libido while running a dry stack (Masteron, Primobolan, or Parabolan); propionate's fast clearance means the testosterone contribution to blood levels is minimal within 5–7 days of stopping, which matters for athletes timing their peak for a show; long-ester testosterone base would leave detectable levels and some degree of E2 aromatization for 2–4 weeks after the last injection
• Users who prefer EOD injection frequency and stable short-ester blood levels — some athletes find that the frequent injection schedule of propionate produces a more stable hormonal environment with fewer fluctuation-related side effects (mood swings, energy variability) compared to long esters injected once or twice weekly; the more frequent dosing creates a flatter blood level curve with smaller peaks and troughs; this profile suits users who are sensitive to estrogen fluctuations
• What differentiates Propionat 100 from long-ester testosterone alternatives: compared to Enantat 250 (enanthate, ~7 day half-life), Propionat 100 has faster onset (1–2 weeks vs 3–4 weeks), requires more frequent injection (EOD vs twice weekly), and allows PCT to begin 3–5 days rather than 2 weeks post-last-injection; compared to Cypionat 250 (cypionate, ~8 day half-life), the practical pharmacological difference in the cycle is minimal — the key distinction is the same fast-clearance advantage of propionate vs long ester; compared to Sustanon 270 (multi-ester blend), propionate alone produces a predictable single-ester kinetic curve without the complex clearance profile of a blend
• Users who should choose a long-ester testosterone instead: users who cannot commit to EOD injection frequency should use Enantat 250 or Cypionat 250 with twice-weekly dosing; first-time AAS users who are still calibrating their E2 management may find the faster fluctuations of a short ester less forgiving than the smoother curve of a long ester; users with a strong needle sensitivity will find propionate's injection frequency (4 injections per week) more demanding than long esters (2 injections per week)

Propionat 100 vs Alternatives

Combinations

Side Effects & Management

Bloodwork Monitoring

PCT

The propionate ester's ~2–3 day half-life is the single most practically significant pharmacokinetic advantage of testosterone propionate over long-ester testosterone formats. Propionat 100 clears to near-baseline within 5–7 days of the last injection, enabling PCT to begin 3–5 days after the last dose — compared to the 2-week wait required after the last enanthate or cypionate injection. This means an 8-week propionate cycle with a standard 4-week PCT has a total cycle-to-recovery timeline 9–11 days shorter than the equivalent long-ester protocol.

Practical Summary

References